These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2671919)

  • 1. [Use of vitamin D 2 and its metabolites in chronic glomerulonephritis in children].
    Naumova VI; Rusnak FI; Vereskova SA; Kutafina EK; Panchenko EL
    Pediatriia; 1989; (5):19-22. PubMed ID: 2671919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic use of vitamin D, its derivatives and their analogs].
    Vagneur JP; Argemi B
    Diabete Metab; 1982 Mar; 8(1):65-7. PubMed ID: 6980150
    [No Abstract]   [Full Text] [Related]  

  • 3. Are new vitamin D analogues in renal bone disease superior to calcitriol?
    Salusky IB
    Pediatr Nephrol; 2005 Mar; 20(3):393-8. PubMed ID: 15690188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of renal osteodystrophy with calciferol (vitamin D) and related steroids.
    Brickman AS; Norman AW
    Kidney Int; 1973 Aug; 4(2):161-7. PubMed ID: 4364427
    [No Abstract]   [Full Text] [Related]  

  • 5. Osteopenia during long-term haemodialysis: response to vitamin D3 analogues.
    Muirhead N; Adami S; Fraser RA; Catto GR; Edward N; O'Riordan JL
    Proc Eur Dial Transplant Assoc; 1981; 18():567-72. PubMed ID: 6895786
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vitamin D deficiency and its correction in children with terminal stage of chronic kidney failure].
    Tsybysheva AK; Burkov IV; Blazhevich NV; Pereverzeva OG; Spirichev VB
    Vopr Med Khim; 1988; 34(4):112-7. PubMed ID: 3264096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of vitamin D analogs in renal osteodystrophy.
    Johnson WJ
    Semin Nephrol; 1986 Mar; 6(1):31-41. PubMed ID: 3037668
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of vitamin D metabolites on indicators of protein, phosphorus and calcium metabolism in children with chronic renal failure].
    Denisova SN; Kutafina EK; Sergeeva TV; Savina MI; Kon' IIa; Shilina NM; Chizhevskaia OL; Shilov AV
    Vopr Pitan; 1999; 68(5-6):35-40. PubMed ID: 10641280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of early treatment of renal bone disease in children.
    Chesney RW; Dabbagh S; Uehling DT; DeLuca HF
    Kidney Int Suppl; 1985 Dec; 17():S75-8. PubMed ID: 3879313
    [No Abstract]   [Full Text] [Related]  

  • 10. The Use of Vitamin D Metabolites and Analogues in the Treatment of Chronic Kidney Disease.
    Zand L; Kumar R
    Endocrinol Metab Clin North Am; 2017 Dec; 46(4):983-1007. PubMed ID: 29080646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative clinical and histomorphological studies on the therapy of renal osteopathy using vitamin D and 5,6-trans-25-OHCC].
    Schulz W; Heidler R; Gessler U; Offermann G; Schulz A; Delling G
    Verh Dtsch Ges Inn Med; 1975; 81():976-80. PubMed ID: 1229631
    [No Abstract]   [Full Text] [Related]  

  • 12. Bone disease in children with chronic renal failure: therapy with 1alpha-hydroxyvitamin D3.
    Postlethwaite RJ; Houston IB
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():117s-124s. PubMed ID: 304772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Case of familial juvenile nephronophthiasis: intestinal calcium absorption and effects of vitamin D 2].
    Kiyono Y; Iida H; Okada H; Shimotsuji T
    Nihon Shonika Gakkai Zasshi; 1972 Jan; 76(1):18-26. PubMed ID: 4537137
    [No Abstract]   [Full Text] [Related]  

  • 14. [Vitamin D status and phosphorus-calcium metabolism in renal and glucocorticoid osteopathies in children].
    Rusnak FI
    Vopr Pitan; 1984; (3):71-2. PubMed ID: 6332423
    [No Abstract]   [Full Text] [Related]  

  • 15. Low-dose vitamin D analogues for renal osteodystrophy.
    Lancet; 1989 Jun; 1(8651):1364-5. PubMed ID: 2567378
    [No Abstract]   [Full Text] [Related]  

  • 16. Renal hypophosphatemic rickets: growth acceleration after long-term treatment with 1,25-dihydroxyvitamin-D3.
    Chan JC; Lovinger RD; Mamunes P
    Pediatrics; 1980 Sep; 66(3):445-54. PubMed ID: 6893489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of erythropoietin, active vitamin D3 metabolites, and alkali agents in predialysis patients.
    Ismail N
    Semin Nephrol; 1997 Jul; 17(4):270-84. PubMed ID: 9241713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure.
    Chan JC; Kodroff MB; Landwehr DM
    Pediatrics; 1981 Oct; 68(4):559-71. PubMed ID: 6895662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ergocalciferol versus calcitriol for controlling chronic kidney disease mineral bone disorder in stage 3 to 5 CKD: A randomized controlled trial.
    Zhang D; Li H; Yin D; Wang L; Ma Y
    Eur J Pharmacol; 2016 Oct; 789():127-133. PubMed ID: 27401037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [News in the management of calcium and phosphorus metabolism disorders for patient treated by hemodialysis].
    Van Overmeire L; Delanaye P; Krzesinski JM
    Rev Med Suisse; 2005 Aug; 1(30):1960-5. PubMed ID: 16200940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.